| __timestamp | Amphastar Pharmaceuticals, Inc. | Ligand Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 40373000 | 22570000 |
| Thursday, January 1, 2015 | 46974000 | 24378000 |
| Friday, January 1, 2016 | 47298000 | 26621000 |
| Sunday, January 1, 2017 | 50918000 | 28653000 |
| Monday, January 1, 2018 | 58044000 | 37734000 |
| Tuesday, January 1, 2019 | 63109000 | 41884000 |
| Wednesday, January 1, 2020 | 65157000 | 64435000 |
| Friday, January 1, 2021 | 68920000 | 57483000 |
| Saturday, January 1, 2022 | 66592000 | 70062000 |
| Sunday, January 1, 2023 | 80393000 | 52790000 |
Igniting the spark of knowledge
In the competitive world of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for profitability. Over the past decade, Amphastar Pharmaceuticals, Inc. and Ligand Pharmaceuticals Incorporated have shown distinct strategies in optimizing these costs.
From 2014 to 2023, Amphastar's SG&A expenses grew by approximately 99%, peaking in 2023. In contrast, Ligand's expenses increased by about 134% during the same period, with a notable spike in 2022. Despite Ligand's higher growth rate, Amphastar maintained a more consistent upward trend, suggesting a steady investment in operational efficiency.
Amphastar's approach reflects a gradual scaling of operations, while Ligand's fluctuating expenses indicate strategic shifts, possibly in response to market dynamics. Understanding these patterns offers valuable insights into how each company navigates the complex landscape of pharmaceutical management.
Cost Management Insights: SG&A Expenses for Genmab A/S and Ligand Pharmaceuticals Incorporated
Jazz Pharmaceuticals plc and Ligand Pharmaceuticals Incorporated: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing Jazz Pharmaceuticals plc and Amphastar Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? Halozyme Therapeutics, Inc. or Ligand Pharmaceuticals Incorporated
Alkermes plc vs Amphastar Pharmaceuticals, Inc.: SG&A Expense Trends
Breaking Down SG&A Expenses: Apellis Pharmaceuticals, Inc. vs Ligand Pharmaceuticals Incorporated
Cost Management Insights: SG&A Expenses for MorphoSys AG and Amphastar Pharmaceuticals, Inc.
Comparing SG&A Expenses: Vericel Corporation vs Amphastar Pharmaceuticals, Inc. Trends and Insights
Comparing SG&A Expenses: HUTCHMED (China) Limited vs Amphastar Pharmaceuticals, Inc. Trends and Insights
Ligand Pharmaceuticals Incorporated vs Dynavax Technologies Corporation: SG&A Expense Trends
Comparing SG&A Expenses: Supernus Pharmaceuticals, Inc. vs Amphastar Pharmaceuticals, Inc. Trends and Insights
Who Optimizes SG&A Costs Better? Amphastar Pharmaceuticals, Inc. or Taro Pharmaceutical Industries Ltd.